Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,523,706
-$1,775,433 QoQ
Shares Held
80,566
-10.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$121,352
PutShares
700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
80,566 | $9,523,706 | |
| 2 | VTRS |
Viatris Inc
|
385,999 | $5,214,846 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,648 | $5,128,091 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
224,015 | $4,148,757 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
121,502 | $2,907,542 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
20,245 | $2,667,076 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,216 | $2,626,945 | |
| 8 | HLN |
Haleon plc
|
247,741 | $2,479,887 |
All Filings in ZTS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,523,706 | 80,566 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,299,139 | 89,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,756,663 | 121,355 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,201,548 | 116,714 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $18,975,583 | 115,248 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $17,834,317 | 109,460 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,278,054 | 108,906 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $18,510,514 | 106,775 | Shares | Sole | 2024-08-22 | |
| 2024-06-30 | $121,352 | 700 | Put | Sole | 2024-08-22 | |
| 2024-03-31 | $16,258,542 | 96,085 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $5,054,448 | 25,609 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,415,786 | 25,381 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,781,903 | 21,961 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,731,751 | 22,421 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,275,539 | 22,351 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,852,438 | 12,492 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $74,145 | 500 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $103,134 | 600 | Put | Sole | 2022-08-11 | |
| 2022-06-30 | $2,243,164 | 13,050 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,318,525 | 12,294 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,179,710 | 13,030 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,442,669 | 12,582 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,737,442 | 14,689 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $31,496 | 200 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $1,928,185 | 12,244 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,518,579 | 15,218 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,203,893 | 7,280 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $762,627 | 5,565 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $646,235 | 5,491 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||